| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Neurodevelopmental disorders, oxycodone/buprenorphine-induced, in pregnant mouse (C57BL/6J)
|
AB78017 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Slc16a2 knockout, in mouse (C57BL/6J)
|
AB78018 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Slc2a3 brain conditional knockout, in mouse (C57BL/6J)
|
AB78019 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Tanc2 +/- conditional knockout, in mouse (C57BL/6J)
|
AB78020 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Tanc2 conditional knockout, in mouse (C57BL/6J)
|
AB78021 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Taok2 +/- conditional knockout, in mouse (C57BL/6J)
|
AB78022 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, Taok2 conditional knockout, in mouse (C57BL/6J)
|
AB78023 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, transgenic (Pvalb/Gad1)/maternal polycytidylic-polyinosinic acid-induced, in mouse (C57BL/6J)
|
AB78024 |
mouse |
Neurodevelopmental disorders |
|
Neurodevelopmental disorders, transgenic (Pvalb/Npy)/maternal polycytidylic-polyinosinic acid-induced, in mouse (C57BL/6J)
|
AB78025 |
mouse |
Neurodevelopmental disorders |
|
Neurogenesis, Adipoq knockout, in mouse (C57BL/6J)
|
AB78026 |
mouse |
Neurological Disorders |